Ellie (Alice) Guardino
Clinical Trials
- A Pilot Study Evaluating the Immunologic Status of Patients with HER2+ Breast Cancer Recruiting
- Healing Touch during Chemotherapy Infusions for Women with Breast Cancer Recruiting
- Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast Recruiting
- Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer Recruiting
- Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA Recruiting
- Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel with Lapatinib in Stage II/III Her2Neu+ Breast Cancer Recruiting
- Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer Recruiting
- Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Recruiting
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Recruiting
- Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Recruiting
- A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer No longer recruiting
- A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer No longer recruiting
- Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer No longer recruiting
- Mixed Chimera Allo Transplantation in Multiple Myeloma No longer recruiting
- Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells Completed
Help
Trial Administration